Last updated on November 2017

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort, as an Active Control, on Lung Function in Subjects with Moderate to Severe COPD


Brief description of study

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort, as an Active Control, on Lung Function in Subjects with Moderate to Severe COPD

Detailed Study Description

This is a 6-month treatment study for patients with moderate to very severe COPD.

Clinical Study Identifier: TX15212

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Lisa Hendrich, RN

Alpine Clinical Research Center
Boulder, CO USA
  Connect »